MedPAC Votes to Recommend Ditching Medicare DSH Patient Percentage for Medicare Purposes

MedPAC wordmark
MedPAC thinks CMS should stop using the Medicare DSH patient percentage for Medicare purposes. The 340B program uses the DSH calculation for hospital eligibility purposes.

The Medicare Payment Advisory Commission, as expected, has voted to recommend that Congress should start phasing in a new way of distributing extra Medicare payments to safety net hospitals that disproportionately serve low-income and/or uninsured beneficiaries.

The proposal that

Read More »

Oregon Bill Targets PBM Policies that Discriminate Against 340B Pharmacies

Oregon House Bill 2716 image
A bill in Oregon would prohibit discriminatory practices by PBMs and insurance plans against 340B pharmacies.

Oregon legislators have introduced a bill that would prohibit discriminatory practices by pharmacy benefit managers and insurance plans against 340B pharmacies, including reimbursing a 340B pharmacy less for prescription drugs compared with non-340B pharmacies. 

If passed later this year, House

Read More »

First 340B-Related Bill of 118th Congress Filed

Screenshot of congress.gov 340B legislation page
The first bill of the 118th Congress to change the 340B program was introduced this week.

U.S. Rep. Matt Rosendale (R-Mont.) has introduced legislation reportedly the same as he filed during the last session of Congress to impose conditions on hospital participation in the 340B program. More bills dealing with 340B are likely.

H.R. 198

Read More »

Nine New Republicans Named to House Committee with 340B Jurisdiction

House E&C wordmark
U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) announced that the panel will have nine new Republicans this session.

U.S. Rep. Cathy McMorris Rodgers (R-Wash.) announced Tuesday that she was named chair of the House Energy & Commerce Committee. She in turn announced yesterday that the House Republican Steering Committee recommended nine new members to serve on the panel.

Read More »

Congressional Committee Lineups Still in Flux After McCarthy Installed as House Speaker

House Speaker Kevin McCarthy in the speaker's chair
U.S. Rep. Kevin McCarthy (R-Calif.) takes the podium Jan. 7 after being elected as House Speaker.

The members, GOP chairs, and top-ranking Democrats of U.S. House committees for the 118th Congress still had not been formally announced this morning, three days after Republicans chose Rep. Kevin McCarthy (R-Calif.) to be House speaker.

It took four days

Read More »

340B Provider Ally Stabenow Will Not Seek Re-Election to U.S. Senate in 2024

Sen. Debbie Stabenow (D-MI) headshot
U.S. Sen. Debbie Stabenow (D-Mich.) will not seek re-election in 2024, depriving 340B covered entities of a reliable ally.

U.S. Sen. Debbie Stabenow (D-Mich.) will not seek re-election in 2024, a decision that will deprive 340B covered entities of a reliable ally in Congress.

Stabenow issued a statement yesterday announcing her decision. She was one of six senators—three

Read More »

House GOP Leadership Spat Stymies All Action, Including Any on 340B

Rep. Kevin McCarthy (R-CA) pictured at the entrance to the West Wing of the White House
The split among House Republicans about whether to pick Rep. Kevin McCarthy (Calif.) to be House Speaker has ground the chamber to a halt.

The U.S. House was frozen stuck this morning after the new Republican majority splintered yesterday, the first day of the 118th Congress, over who should be the next House speaker.

Representatives cannot be sworn in and the House cannot begin

Read More »

Office of Pharmacy Affairs Get Slight Funding Bump

HRSA building and signage
HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.

President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.

The U.S. Health Resources and Services Administration’s Office of Pharmacy Affairs will get

Read More »

Breaking: Congress Wants HRSA Briefing on Action to Safeguard 340B Entities’ “Lawful Access to Discounted Drugs”

Senate Appropriations committee room
The U.S. Senate Appropriations Committee released an omnibus FY 2023 spending bill late yesterday with report language requesting a HRSA briefing on its actions to safeguard providers' access to 340B drug discounts.

U.S. House and Senate appropriations committees want federal healthcare officials to brief them by April “on actions taken to safeguard covered entities’ lawful access to discounted drugs” under the 340B program.

The directive to the Health Resources and Services Administration

Read More »

117th Congress Nears End With No 340B Contract Pharmacy Fix Expected

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.

The 117th Congress appears destined to end without further action on the 340B program.

The House and Senate are on track to finish all work for the year by no later than Friday, Dec. 23. According to news reports yesterday,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live